Victor M. Rivera
Baylor College of Medicine(US)Takeda (Japan)(JP)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance(2009)1,234 cited
- → A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias(2013)1,111 cited
- → Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias(2012)762 cited
- → Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial(2018)576 cited
- → A humanized system for pharmacologic control of gene expression(1996)541 cited
- → Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK(2011)538 cited